High-Quality Ensures Safety

Parasorb Resodont® Forte is produced in Germany from very high-purity collagen of equine origin ensuring the highest degree of product safety. The collagen is completely absorbed, meaning no secondary surgical procedure is necessary, which is required if non-absorbable membranes are used.

Special Microstructure

The barrier function of Parasorb Resodont® Forte prevents the in-growth of connective tissue, whilst the surface structure of the membrane still permits the growth of bone-forming cells.

Meet High Demands

Typically, high demands are placed on every membrane in the field of GTR/GBR.

Primarily, these include biocompatibility, integration into the surrounding tissue, intraoperative handling, as well as duration of the barrier function. Resorba® membranes meet these requirements in an ideal manner.

Resodont® Forte contains 6-8mg equine, native collagen fibrils per square centimetre. It features very high tear resistance, considerably extended standing time - without chemical additives, and simple tailoring under dry and wet conditions.

Key Benefits

The key benefits of the Resorba Resodont® Forte Collagen Membrane include:

  • Barrier function of 8-12 weeks
  • High tear resistance - 0.1mm-0.36mm thickness
  • Extended standing time, without chemical additives
  • Simple tailoring under wet or dry conditions
  • Fully resorbable
  • Osteoconductive
  • Angioconductive
  • Supports wound healing
  • Rapid integration into surrounding tissue
  • Either side against tissue or bone
  • Quick and easy to cut to size and apply

The membrane is used in dental and in oral and maxillofacial surgery, mainly in guided bone regeneration (GBR) to cover defects and to secure augmentation material.

The area includes local augmentation before or during the insertion of endosteal implants, covering the facial maxillary sinus mucosa in sinus lift operations and covering alveoli after extractions...

...The wound healing process occurred without any infection or foreign body reactions, and, in all cases to date, the barrier function has been adequate for unimpaired bony consolidation.

If the membrane is exposed due to dehisences, immediate removal is not indicated, as consistent disinfectant irrigation treatment can achieve secondary epithelisation of the membrane without disturbing the underlying augmentation."

Prof. Dr. Dr. J. Kleinheiz, Clinic and Policlinic for Oral and Maxillofacial Surgery, Muenster University Hospital, Germany.

Bioequivalence Study of Two Collagen Membranes as Part of Dento-Alveolar Guided Bone Regeneration (GBR)

Introduction: A number of collagen membranes with different manufacturing processes are available in the field of GBR. The aim of this study was the evaluation and comparison of two different membranes (PARASORB RESODONT®, Resorba, Nuremberg, Germany and Bio-Gide®, Geistlich, Wolhusen, Switzerland) in clinical use.

Summary and Final Assessment: Both membranes represent a safe and reliable solution for covering grafts in selected indication as part of GBR. The membranes can be well adapted to the desired shape and size, application and adaptation in the wound area do not present problems. In dry condition, both membranes tend to stick to wet gloves and should therefore only be handled and processed with instruments.

Wetting outside the wound appears sensible to avoid tearing of the dry membranes during intra-oral adaptation. In wetted version, both membranes can be well adapted to any anatomical situation. Additional fixation with sutures or pins does not seem necessary as both membranes adapt tightly to the underlying graft after wetting and dislocations hardly occur. So far no membrane-associated changes such as dehiscence, bacterial infection, swelling or reactions to foreign matter have been observed during the postoperative process, wound healing was primary in most cases.

Based on the observations and experiences made, there is no principal difference between the two membranes.

Prof. Dr. J Kleinheinz, Clinic and Policlinic for Oral and Maxillofacial Surgery, Muenster University Hospital, Germany.